Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
University of Brasilia
Enrollment target
~100 participants
Primary completion
June 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
50 Years and older
Last updated September 2023